TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer

Name: TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
License: Public Domain

Memorial Sloan Kettering Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

ovarian-cancer

ovarian cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 180205
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.